USPTO serial 79296424
AM PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 5, 2022
- Examiner
- MCDORMAN, ROGER THOMAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AM PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for the treatment and prevention of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; sanitary preparations for medical use; plasters for medical purposes, materials for medical and surgical dressings; disinfectants; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders | ACTIVE | — |
| 042 | Scientific and technological services and research and design services related thereto, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely, scientific research, analysis, and reporting in the field of medicine; industrial analysis and industrial research in the field of medicine; development of technologies in the field of diagnostics, pharmaceuticals; biotechnological research related to enzymatic synthesis; testing of pharmaceuticals; quality control of goods and services; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research being pharmaceutical drug development services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; medical research and clinical research in the field of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergic diseases; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for pharmaceutical products of others | ACTIVE | — |
| 044 | Services in the field of hygienic and beauty care for human beings | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AM-Pharma B.V.
- Other trademarks owned by AM-Pharma B.V.
- Other trademarks owned by AM-Pharma B.V.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AM PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 10, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 5, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 23, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 29, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 18, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 18, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 29, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 29, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 29, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 10, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 16, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 18, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 18, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 30, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 28, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |